Natural Alternatives International, Inc. (NAII): Price and Financial Metrics

Natural Alternatives International, Inc. (NAII): $7.49

-0.24 (-3.10%)

POWR Rating

Component Grades








Add NAII to Watchlist
Sign Up

Industry: Medical - Consumer Goods




#3 of 10

in industry

NAII Price/Volume Stats

Current price $7.49 52-week high $12.60
Prev. close $7.73 52-week low $7.00
Day low $7.49 Volume 284
Day high $7.66 Avg. volume 7,596
50-day MA $8.25 Dividend yield N/A
200-day MA $8.93 Market Cap 45.24M

NAII Stock Price Chart Interactive Chart >

NAII Stock Summary

  • NAII has a market capitalization of $48,192,299 -- more than approximately only 14.56% of US stocks.
  • Of note is the ratio of NATURAL ALTERNATIVES INTERNATIONAL INC's sales and general administrative expense to its total operating expenses; 87.44% of US stocks have a lower such ratio.
  • With a price/sales ratio of 0.28, NATURAL ALTERNATIVES INTERNATIONAL INC has a higher such ratio than just 9.98% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to NATURAL ALTERNATIVES INTERNATIONAL INC are REX, NVFY, MPX, HWKN, and CSWI.
  • NAII's SEC filings can be seen here. And to visit NATURAL ALTERNATIVES INTERNATIONAL INC's official web site, go to

NAII Valuation Summary

  • In comparison to the median Consumer Defensive stock, NAII's price/earnings ratio is 39.39% lower, now standing at 13.
  • Over the past 243 months, NAII's price/sales ratio has gone down 0.1.

Below are key valuation metrics over time for NAII.

Stock Date P/S P/B P/E EV/EBIT
NAII 2023-05-23 0.3 0.5 13.0 14.1
NAII 2023-05-22 0.3 0.5 12.8 14.0
NAII 2023-05-19 0.3 0.5 13.0 14.1
NAII 2023-05-18 0.3 0.5 13.1 14.3
NAII 2023-05-17 0.3 0.5 13.0 14.2
NAII 2023-05-16 0.3 0.5 12.7 14.0

NAII Growth Metrics

    Its 4 year cash and equivalents growth rate is now at 47.46%.
  • Its 3 year cash and equivalents growth rate is now at -32.85%.
  • Its 4 year net income to common stockholders growth rate is now at -139.77%.
Over the past 34 months, NAII's revenue has gone up $66,281,000.

The table below shows NAII's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 180.321 16.158 8.475
2022-09-30 175.753 11.082 8.509
2022-06-30 170.966 11.866 10.712
2022-03-31 162.831 7.929 10.569
2021-12-31 166.778 15.566 9.981
2021-09-30 177.134 16.92 11.766

NAII's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NAII has a Quality Grade of B, ranking ahead of 75.9% of graded US stocks.
  • NAII's asset turnover comes in at 1.449 -- ranking 10th of 682 Pharmaceutical Products stocks.
  • KMPH, REPH, and BMY are the stocks whose asset turnover ratios are most correlated with NAII.

The table below shows NAII's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.449 0.171 0.139
2021-03-31 1.374 0.172 0.119
2020-12-31 1.205 0.169 0.045
2020-09-30 1.086 0.158 0.000
2020-06-30 1.026 0.159 -0.018
2020-03-31 1.045 0.140 -0.049

Natural Alternatives International, Inc. (NAII) Company Bio

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. The company was founded in 1980 and is based in Carlsbad, California.

NAII Latest News Stream

Event/Time News Detail
Loading, please wait...

NAII Latest Social Stream

Loading social stream, please wait...

View Full NAII Social Stream

Latest NAII News From Around the Web

Below are the latest news stories about NATURAL ALTERNATIVES INTERNATIONAL INC that investors may wish to consider to help them evaluate NAII as an investment opportunity.

SR CarnoSyn® Sustained Release Beta-Alanine Selected as Finalist for Ingredient of the Year in Healthy Aging and Cognitive Function by NutraIngredients-USA Awards 2023

CarnoSyn® Brands and parent company Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), are proud to announce that SR CarnoSyn® sustained release beta-alanine has been selected as a finalist in this year's NutraIngredients-USA Awards in two categories: Ingredient of the Year: Healthy Aging and Ingredient of the Year: Cognitive Function.

Yahoo | May 31, 2023

Natural Alternatives International Strengthens Capabilities by Adding New U.S. Manufacturing Facility in California

Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII) today announced the expansion of its global dietary supplement contract manufacturing network, providing the ability to better service existing customers, attract new customers, expand sales, and provide potential for channel and customer diversification.

Yahoo | May 24, 2023

Researchers Behind Recent Publication on SR CarnoSyn® Beta-Alanine Tablet's Ability to Improve Cognitive Health Presenting at American College of Sports Medicine and Exercise Science (ACSM) 2023 Annual Meeting

CarnoSyn® Brands and parent company Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), are proud to sponsor Dr. Guilherme G. Artioli and announce that several other leading CarnoSyn® beta-alanine researchers will be presenting at the American College of Sports Medicine and Exercise Science (ACSM) Annual Meeting and World Congresses Conference in Denver, CO on May 30-June 2, 2023.

Yahoo | May 17, 2023

Natural Alternatives GAAP EPS of -$0.41, revenue of $32.7M; updates FY23 guidance

  • Natural Alternatives press release (NASDAQ:NAII): Q3 GAAP EPS of -$0.41.
  • Revenue of $32.7M (-22.9% Y/Y).
  • Outlook: While our sales decreased further than anticipated during the third quarter of fiscal 2023, we expect our sales during the fourth quarter of fiscal 2023 will increase as compared to the third quarter.
  • Based on our current sales order volum...

    Seeking Alpha | May 16, 2023

Natural Alternatives International, Inc. Announces 2023 Q3 and YTD Results

Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.4 million, or $0.41 per diluted share, on net sales of $32.7 million for the third quarter of fiscal year 2023 compared to net income of $2.5 million, or $0.41 per diluted share, in the third quarter of the prior fiscal year.

Yahoo | May 15, 2023

Read More 'NAII' Stories Here

NAII Price Returns

1-mo -2.73%
3-mo -16.45%
6-mo -5.07%
1-year -30.00%
3-year 6.54%
5-year -30.97%
YTD -10.73%
2022 -33.68%
2021 19.46%
2020 32.69%
2019 -18.82%
2018 -4.56%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!